Published in Biom J on August 01, 2006
A regulatory view on adaptive/flexible clinical trial design. Biom J (2006) 2.28
FDA's critical path initiative: a perspective on contributions of biostatistics. Biom J (2006) 1.98
Confirmatory clinical trials with an adaptive design. Biom J (2006) 1.91
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biom J (2006) 2.61
Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests. Biom J (2011) 2.45
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biom J (2006) 2.16
A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71
Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies. Stat Med (2007) 1.16
Hierarchical testing of multiple endpoints in group-sequential trials. Stat Med (2010) 1.04
Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures. Stat Med (2011) 0.95
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat (2007) 0.90
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim. Pharm Stat (2012) 0.83
Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. Biom J (2009) 0.80
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion. J Biopharm Stat (2010) 0.79
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods. Stat Med (2012) 0.77
Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research. J Biopharm Stat (2011) 0.77
Author's reply: To PMID 21837623. Biom J (2013) 0.75